Tu1327a Golimumab for Treatment of Moderate to Severe Anti-TNF Refaractory Crohn's Disease: Open Label Experience

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gastroenterology

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0016-5085(12)63121-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection

  2024cites this paper
• Recent advances in the treatment of IBD: Targets, mechanisms and related therapies.

  2023cites this paper
• Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody

  2020cites this paper
• Application of Pharmacometrics and Systems Pharmacology to Current and Emerging Biologics in Inflammatory Bowel Diseases

  2019cites this paper
• Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

  2018cites this paper
• Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation

  2018cites this paper
• Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease

  2017cites this paper
• Patterns of anti-TNF use and associated treatment outcomes in inflammatory bowel disease patients: results from an analysis of Dutch health insurance claims data.

  2017cites this paper
• Nephrotic syndrome under treatment with dasatinib: be aware of a possible adverse drug reaction.

  2017influential citation
• Anti-TNF-α therapies for the treatment of Crohn’s disease: the past, present and future

  2016cites this paper
• Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults

  2016cites this paper
• Novel concepts in inflammatory bowel disease.

  2014cites this paper
• Novel concepts in in fl ammatory bowel disease

  2014cites this paper